Showing results (191-200 of 541) with videos related to
Sort By:
Pageof 55
Biochemical Pharmacology|July 1, 1988
Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lungZ Terashita, G L Stahl, A M LeferEuropean Journal of Pharmacology|October 7, 1998
Effects of LEX032, a novel recombinant serine protease inhibitor, on N(G)-nitro-L-arginine methyl ester induced leukocyte-endothelial cell interactionsA S Bains, R Scalia, A M LeferArchives Internationales De Pharmacodynamie Et De Therapie|January 1, 1981
Biphasic actions of chlorpromazine and mepacrine on modulation of hepatic cell injury in the perfused cat liverH Araki, R C Peck, A M LeferCirculatory Shock|March 1, 1988
Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shockH Bitterman, B A Smith, A M LeferScientific Reports|November 8, 2013
Local decomposition induced by dislocation motions inside tetragonal Al(2)Cu compound: slip system-dependent dynamicsD Chen, X L MaProstaglandins|May 1, 1979
Beneficial actions of prostacyclin in traumatic shockA M Lefer, S L Sollott, M J GalvinJournal of the American College of Cardiology|May 1, 1984
Potentiation of coronary vascular platelet adhesion by atrial pacing in the presence of arterial stenosis in dogsP Walinsky, A M Lefer, P Frasca, et al.The American Journal of Physiology|March 1, 1976
Release of prostaglandin F2alpha during splanchnic artery occlusion shockJ T Flynn, G A Bridenbaugh, A M LeferEuropean Journal of Pharmacology|March 18, 1986
Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemiaC E Hock, M E Brezinski, A M LeferCanadian Journal of Physiology and Pharmacology|August 1, 1976
Lack of a significant protective effect of augmented circulating glucose on the ischemic myocardium.BJJ A Spath, M L Ogletree, A M LeferPageof 55